혈액은행 장비 시장 : 제품별, 기능별, 최종사용자별 - 세계 예측(-2030년)

Blood Banking Equipment Market Size, Share, Forecast, & Trends Analysis by Product (Collection [Tubes, Bags, Syringes], Processing [Centrifuge, Filter, Processor], Storage [Refrigerator, Freezer]), Functionality (Automated, Manual) - Global Forecast to 2030

The blood banking equipment market is projected to reach $24.26 billion by 2030, at a CAGR of 4.6% from 2023 to 2030. Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, opportunities, and trends

The growth of this market is driven by the rising demand for blood and blood-related products, the increasing number of surgical procedures being performed globally, and technological advancements and automation in blood banking devices. In addition, untapped opportunities in emerging countries and the supportive initiatives to promote blood transfusion offer significant opportunities for the growth of this market.

Based on product type, in 2023, the blood collection equipment segment is expected to account for the largest share of the blood banking equipment market. The large market share of this segment is attributed to the increasing incidence of trauma & accidents, the increasing number of surgical procedures being performed globally, and the rising prevalence of chronic diseases. Blood banks are involved in various tasks, including blood donations, storage & transportation, and blood typing during transfusion, and blood testing.

Based on the functionality, the blood banking equipment market is segmented into automated blood banking equipment and manual blood banking equipment. In 2023, the manual blood banking equipment segment is expected to account for the largest share of the blood banking equipment market. The large market share of this segment is attributed to the benefits offered by manual equipment, such as low cost, less time for training the staff, and ease of use, resulting in increased adoption. Manual blood processing devices such as analyzers or fractionators require less time and low cost in training lab personnel, making it an economically viable choice for blood banks.

Based on source, the blood banking equipment market is segmented into mice, rabbits, and other sources. In 2024, the mice segment is expected to account for the largest share of the market. Due to the availability, low cost, and quick production time for mouse mAbs, humanization of mouse mAbs has been implemented on a large scale. Furthermore, mouse farming is easier than rabbit farming, and the genetic approaches to engineering antibodies through recombinant technologies are more established for mice than other animals, making mice a preferred choice for antibody production.

Based on end user, in 2023, the blood banks segment is expected to account for the largest share of the blood banking equipment market. The large market share of this segment is attributed to the rising number of surgeries performed globally and the subsequent increase in demand for blood and blood products from blood banks. Blood banks are the primary source of blood or blood-related products; hence, the demand for collection, processing, and storage equipment is higher in blood banks.

An in-depth analysis of the geographical scenario of the blood banking equipment market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to account for the largest share of the global blood banking equipment market in 2024, followed by Europe and Asia-Pacific. In 2023, North America is expected to account for the largest share of the blood banking equipment market. North America's major market share is attributed to the high healthcare spending; the high demand for blood or related components such as whole blood, RBCs, WBCs, plasma, platelets and others; and initiatives promoting blood donations in the U.S.

Key companies operating in the blood banking equipment market are Abbott Laboratories (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Fresenius Kabi AG (Germany), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux SA (France), HORIBA, Ltd. (Japan), Mindray Bio-Medical Electronics Co, Ltd (U.S.), Sysmex Corporation (Japan), and Hamilton Bonaduz AG (Switzerland).

Scope of the Report:

Blood Banking Equipment Market, by Product

• Blood Collection Equipment
  • Needles
  • Tubes
  • Syringes
  • Blood Bags
  • Lancets
  • IV Cannulas
  • Vials
  • Other Blood Collection Equipment

(Note: Other blood collection equipment includes reagents, tube sealers, and collection monitors)

• Blood Processing Equipment
  • Centrifuges
  • Blood Filters
  • Blood Analyzers
  • Blood Processors
  • Other Blood Processing Equipment

(Note: Other blood processing equipment include blood warmers, sedimentation tubes, and plasma thawing bags)

• Blood Storage Equipment
  • Blood Bank Refrigerators
  • Blood Bank Freezers
  • Test Tube Racks

Blood Banking Equipment Market, by Functionality

• Automated Blood Banking Equipment
• Manual Blood Banking Equipment

Blood Banking Equipment Market, by End User

• Blood Banks
  • Private
  • Public
  • Hybrid
• Hospitals

Blood Banking Equipment Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency
• 1.4. Key Stakeholder

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Assessment
  • 2.3.1. Market Size Estimation
    • 2.3.1.1. Bottom-up Approach
    • 2.3.1.2. Top-down Approach
    • 2.3.1.3. Growth Forecast
  • 2.3.2. Market Share Analysis
• 2.4. Assumptions for the Study
• 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

• 4.1. Market Overview
• 4.2. Drivers
  • 4.2.1. Growing Demand for Blood and Blood-related Products
  • 4.2.2. Increasing Number of Surgical Procedures
  • 4.2.3. Technological Advancements and Automation in Blood Banking Devices
• 4.3. Restraints
  • 4.3.1. High Costs of Advanced Blood-related Equipment
  • 4.3.2. Shortage of Skilled Laboratory Experts
• 4.4. Opportunities
  • 4.4.1. Emerging Economies
  • 4.4.2. Supportive Initiatives to Promote Blood Transfusion
• 4.5. Challenge
  • 4.5.1. Blood Supply Shortage
• 4.6 Impact of COVID-19 on the Blood Banking Equipment Market
• 4.7 Regulatory Analysis

5. Global Blood Banking Equipment Market, by Product

• 5.1. Introduction
• 5.2. Blood Collection Equipment
  • 5.2.1. Needles
  • 5.2.2. Tubes
  • 5.2.3. Syringes
  • 5.2.4. Blood Bags
  • 5.2.5. Lancets
  • 5.2.6. IV Cannulas
  • 5.2.7. Vials
  • 5.2.8. Other Collection Equipment
• 5.3. Blood Processing Equipment
  • 5.3.1. Centrifuges
  • 5.3.2. Blood Filters
  • 5.3.3. Blood Analyzers
  • 5.3.4. Blood Processors
  • 5.3.5. Other Processing Equipment
• 5.4. Blood Storage Equipment
  • 5.4.1. Blood Bank Refrigerators
  • 5.4.2. Blood Bank Freezers
  • 5.4.3. Test Tube Racks

6. Global Blood Banking Equipment Market, by Functionality

• 6.1. Introduction
• 6.2. Automated Blood Banking Equipment
• 6.3. Manual Blood Banking Equipment

7. Global Blood Banking Equipment Market, by End User

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Blood Banks
  • 7.3.1. Private
  • 7.3.2. Public
  • 7.3.3. Hybrid

8. Blood Banking Equipment Market, by Geography

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. U.K.
  • 8.3.2. Germany
  • 8.3.3. France
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Rest of Asia-Pacific
• 8.5. Latin America
  • 8.5.1. Brazil
  • 8.5.2. Mexico
  • 8.5.3. Rest of Latin America
• 8.6. Middle East & Africa

9. Competitive Landscape

• 9.1. Introduction
• 9.2. Key Growth Strategies
• 9.3. Competitive Benchmarking
• 9.4. Market Share Analysis (2022)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

• 10.1. Abbott Laboratories
• 10.2. F. Hoffman-La Roche Ltd.
• 10.3. Thermo Fisher Scientific Inc.
• 10.4. Danaher Corporation
• 10.5. Fresenius Kabi AG
• 10.6. Becton, Dickinson and Company
• 10.7. Terumo Corporation
• 10.8. Bio-Rad Laboratories, Inc.
• 10.9. bioMerieux SA
• 10.10. HORIBA, Ltd.
• 10.11. Mindray Bio-Medical Electronics Co, Ltd
• 10.12. Sysmex Corporation
• 10.13. Hamilton Bonaduz AG

11. Appendix

• 11.1. Questionnaire
• 11.2. Available Customization